Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia

Journal of Medical Microbiology

Volumn 55, Issue 10, 2006, Pages 1413-1418

  Ignatova, Anna ^a   Dubiley, Svetlana ^a   Stepanshina, Valentina ^b   Shemyakin, Igor ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STAIN LAM; BACTERIAL STRAIN; BACTERIAL STRAIN BEIJING; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; COST OF ILLNESS; DNA FINGERPRINTING; DRUG SENSITIVITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; PRISON; RUSSIAN FEDERATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL TYPING TECHNIQUES; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, SPECIAL; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRISONERS; RIFAMPIN; RISK FACTORS; RUSSIA; SPECIES SPECIFICITY; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33750434487     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46575-0     Document Type: Article

References (30)

1. Bifani, P. J., Plikaytis, B. B., Kapur, V. & 10 other authors (1996). Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (J Am Med Assoc) 275, 452-457.
2. Bobrik, A., Danishevski, K., Eroshina, K. & McKee, M. (2005). Prison health in Russia: the larger picture. J Public Health Policy 26, 30-59.
3. Brudey, K., Driscoll, J. R., Rigouts, L. & 63 other authors (2006). Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6, 23.
4. Chaulk, C. P. & Kazandjian, V. A. (1998). Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA (J Am Med Assoc) 279, 943-948.
5. Dubiley, S., Mayorova, A., Ignatova, A., Kirillov, E., Stepanshina, V., Kolesnikov, A. & Shemyakin, I. (2005). New PCR-based assay for detection of common mutations associated with rifampin and isoniazid resistance in Mycobacterium tuberculosis. Clin Chem 51, 447-450.
6. Frothingham, R. & Meeker-O'Connell, W. A. (1998). Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 144, 1189-1196.
7. Generozov, E. V., Akopian, T. A., Govorun, V. M., Chernousova, L. N., Larionova, E. E., Savinkova, S. N., Smirnova, T. G., Golyshevskaya, V. I. & Khomenko, A. G. (2000). Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia. Mol Gen Mikrobiol Virusol part 1, 11-17 (in Russian).
8. Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K. & van Soolingen, D. (2002). Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8, 843-849.
9. Hacek, D. (1992). Modified proportion agar dilution test for slowly growing mycobacteria. In Clinical Microbiology Procedures Handbook, vol. 1, pp. 5.13.1-5.13.15. Edited by H. Isenberg. Washington, DC: American Society for Microbiology.
10. Ikeda, R. M., Birkhead, G. S., DiFerdinando, G. T., Jr, Bornstein, D. L., Dooley, S. W., Kubica, G. P. & Morse, D. L. (1995). Nosocomial tuberculosis: an outbreak of a strain resistant to seven drugs. Infect Control Hosp Epidemiol 16, 152-159.
11. Jones, T. F., Craig, A. S., Valway, S. E., Woodley, C. L. & Schaffner, W. (1999). Transmission of tuberculosis in a jail. Ann Intern Med 131, 557-563.
12. Kamerbeek, J., Schouls, L., Kolk, A. & 8 other authors (1997). Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35, 907-914.
13. Kent, P. T. & Kubica, G. P. (1985). Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta: Centers for Disease Control and Prevention.
14. Kononets, A. S., Sidorova, S. V. & Safonova, S. G. (2004). Organization of antituberculous care in penitentiary facilities. Probl Tuberk Bolezn Legk 11, 18-20 (in Russian).
15. Milan, S. J., Hauge, K. A., Kurepina, N. E. & 7 other authors (2004). Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States. J Clin Microbiol 42, 1064-1068.
16. Niemann, S., Rüsch-Gerdes, S., Richter, E., Thielen, H., Heykes-Uden, H. & Diel, R. (2000). Stability of IS6110 restriction fragment length polymorphism patterns of Mycobacterium tuberculosis strains in actual chains of transmission. J Clin Microbiol 38, 2563-2567.
17. Nikolayevsky, V., Brown, T., Balabanova, Y., Ruddy, M., Fedorin, I. & Drobniewski, F. (2004). Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol 42, 4498-4502.
18. Portugal, I., Covas, M. J., Brum, L., Viveiros, M., Ferrinho, P., Moniz-Pereira, J. & David, H. (1999). Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 3, 207-213.
19. Ramaswamy, S. & Musser, J. M. (1998). Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79, 3-29.
20. Ruddy, M., Balabanova, Y., Graham, C. & 12 other authors (2005). Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60, 130-135.
21. Shemyakin, I. G., Stepanshina, V. N., Ivanov, I. Y., Lipin, M. Y., Anisimova, V. A., Onasenko, A. G., Korobova, O. V. & Shinnick, T. M. (2004). Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 8, 1194-1203.
22. Shilova, M. (2003). Tuberculosis in various Federal Districts of Russia. In Abstracts of the 7th Russian Congress of Phthisiatrists, Tuberculosis Today, abstract 31. Moscow: BINOM.
23. Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S. & Musser, J. M. (1997). Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94, 9869-9874.
24. Toungoussova, O. S., Mariandyshev, A., Bjune, G., Sandven, P. & Caugant, D. A. (2003). Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 37, 665-672.
25. van der Spuy, G. D., Warren, R. M., Richardson, M., Beyers, N., Behr, M. A. & van Helden, P. D. (2003). Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J Clin Microbiol 41, 5640-5644.
26. van Embden, J. D. A., Cave, M. D., Crawford, J. T. & 8 other authors (1993). Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31, 406-409.
27. Van Rie, A., Warren, R., Mshanga, I. & 9 other authors (2001). Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39, 636-641.
28. Warren, R. M., van der Spuy, G. D., Richardson, M., Beyers, N., Booysen, C., Behr, M. A. & van Helden, P. D. (2002). Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis. J Clin Microbiol 40, 1277-1282.
29. World Health Organization (1993). Treatment of Tuberculosis. Guidelines for National Programs. Geneva: World Health Organization.
30. Yeh, R. W., Ponce de Leon, A., Agasino, C. B., Hahn, J. A., Daley, C. L., Hopewell, P. C. & Small, P. M. (1998). Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis 177, 1107-1111.